Home›Compare›MyMenopauseRx vs Raeliva

MyMenopauseRx vs Raeliva: Which Is Better?

Head-to-head comparison of MyMenopauseRx and Raeliva based on our independent scoring across trust, value, experience, product range, and reputation — plus real pricing for the treatments they both offer.

Our Verdict

MyMenopauseRx scores higher overall in our independent evaluation (61.3/100 vs 61.2/100), leading on trust & safety, reputation. Raeliva comes out ahead on value, experience, product range. Raeliva has the lower entry price (from $117/mo vs $150/mo), so the better value depends on which treatment you need.

Gynecologist-founded virtual menopause practice that bills most commercial insurance or charges $150 per self-pay visit, prescribing FDA-approved HRT, non-hormonal therapy and branded GLP-1s to local pharmacies.

Visit MyMenopauseRx
61

Raeliva is a 2026-launched GLP-1 and longevity storefront built on the CareValidate platform, with flat dose-independent pricing and prepay discounts.

Visit Raeliva

Score Breakdown

DimensionMyMenopauseRxRaeliva
Overall Score61.3/100 ✓61.2/100
Trust & Safety30%74/100 ✓60/100
Value25%58/10072/100 ✓
Experience20%58/10062/100 ✓
Product Range15%50/10055/100 ✓
Reputation10%55/100 ✓45/100

At a Glance

Founded20212026
HeadquartersChicago area, ILSan Diego, CA
Publicly tradedNoNo
Treatment categories32
Treatments listed37
Starting price$150/mo$117/mo

Pricing Where They Compete

Prices shown are based on our most recent research and may not reflect current pricing. Telehealth providers update their pricing frequently. Always verify pricing directly with the provider before purchasing.

CategoryMyMenopauseRxRaeliva
Weight Loss / GLP-1—$150–$219
Compounded Semaglutide Injections

MyMenopauseRx

+Founder and clinicians are named, and most hold Menopause Society certification (MSCP); patients can keep the same clinician
+In-network with major commercial plans, so many insured patients pay only a copay; $150 flat self-pay rate otherwise
+Prescribes FDA-approved therapies to the patient's local pharmacy, and labs can be ordered on demand at discounted self-pay rates
−No cash-pay medication pricing; the cost of HRT or branded GLP-1s depends on the patient's pharmacy and insurance
−Doesn't accept Medicare, Medicaid or HMO plans, and testosterone is offered only in Illinois
−Very thin public reviews (Trustpilot 3.3/5 on 4), including complaints of rushed visits and repeated charges
Read the full MyMenopauseRx review →

Raeliva

+Clear operator disclosure: names the platform operator, the billing/intake vendor (CareValidate), the medical group (Lion MDs, with physician NPIs) and six dispensing pharmacies
+Flat pricing at every dose for semaglutide and tirzepatide, published on each product page
+Accepts transfers at the patient's current GLP-1 dose after provider review, with no charge if not eligible
−Launched in 2026 with ~1,500 claimed patients and only 12 Trustpilot reviews, all five-star and posted within two months
−Lowest advertised rates require 6- or 12-month prepayment ($900–1,450 upfront), and dispensed medication is non-refundable
−Runs on CareValidate's white-label telehealth stack, so the clinical and billing experience is shared with other storefronts
Read the full Raeliva review →

MyMenopauseRx vs Raeliva — FAQ

Is MyMenopauseRx better than Raeliva?

▾

MyMenopauseRx scores higher overall in our independent evaluation (61.3/100 vs 61.2/100), leading on trust & safety, reputation. Raeliva comes out ahead on value, experience, product range. Raeliva has the lower entry price (from $117/mo vs $150/mo), so the better value depends on which treatment you need.

Is MyMenopauseRx or Raeliva cheaper?

▾

Raeliva has the lower starting price (from $117/mo vs $150/mo for MyMenopauseRx). Starting prices are for the cheapest treatment each offers — compare the specific treatment you need, and check what each price includes.

What do MyMenopauseRx and Raeliva both offer?

▾

Both platforms treat Weight Loss / GLP-1. MyMenopauseRx covers 3 treatment categories total and Raeliva covers 2.

Still deciding?